SinoFresh adds R&D capability

VENICE - SinoFresh HealthCare Inc., a publicly traded company, today acquired SRS International Inc., a research and development firm based in Virginia, in an all-stock deal.

The acquisition will help SinoFresh develop three new medicinal products, two of which are nearly ready to be manufactured, according to David Olund, CEO at SinoFresh.

SRS' expertise in both FDA compliance and medicinal claim support will help make new SinoFresh products more marketable. For example, proper claim support could help SinoFresh market products as disease-treating, rather than symptom-relieving, Olund explained.